Cargando…
Vaccinations versus Lockdowns to Prevent COVID-19 Mortality
Measures employed to combat COVID-19 included public lockdowns and vaccination campaigns. Israel’s extensive public health system produced data demonstrating the real-world results of these measures. Our objective was to evaluate the health and economic outcomes of the measures to cope with COVID-19...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413824/ https://www.ncbi.nlm.nih.gov/pubmed/36016236 http://dx.doi.org/10.3390/vaccines10081347 |
_version_ | 1784775845007589376 |
---|---|
author | Arbel, Ronen Pliskin, Joseph |
author_facet | Arbel, Ronen Pliskin, Joseph |
author_sort | Arbel, Ronen |
collection | PubMed |
description | Measures employed to combat COVID-19 included public lockdowns and vaccination campaigns. Israel’s extensive public health system produced data demonstrating the real-world results of these measures. Our objective was to evaluate the health and economic outcomes of the measures to cope with COVID-19. Publicly available datasets from the Israeli Ministry of Health were used to model the parameters of the pandemic in Israel. The Oxford COVID-19 Government Response Tracker was used for quantitative data on government policies. Data on the Israeli economy were taken from the Central Bureau of Statistics. Our models demonstrate that the first lockdown prevented 1022 COVID-19 deaths at the cost of 36.4–38.6 billion NIS. The second lockdown prevented 1970 COVID-19 deaths and cost 18–21 billion NIS. These lifesaving effects were observed with a time lag from the declaration of lockdown. The primary vaccination campaign cost 1 billion NIS and prevented 4750 COVID-19 deaths. The first vaccination booster campaign prevented 650 COVID-19 deaths and cost 51.1 million NIS. Therefore, the cost per prevented COVID-19 death is 10–36 million NIS with a national lockdown versus 210,000 NIS in the primary vaccination campaign and 79,000 NIS in the first booster campaign. In conclusion, both lockdowns and vaccination campaigns effectively lower COVID-19 deaths, but the cost to avoid one COVID-19 death with effective vaccination is 50–466 times lower than with a lockdown. |
format | Online Article Text |
id | pubmed-9413824 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94138242022-08-27 Vaccinations versus Lockdowns to Prevent COVID-19 Mortality Arbel, Ronen Pliskin, Joseph Vaccines (Basel) Communication Measures employed to combat COVID-19 included public lockdowns and vaccination campaigns. Israel’s extensive public health system produced data demonstrating the real-world results of these measures. Our objective was to evaluate the health and economic outcomes of the measures to cope with COVID-19. Publicly available datasets from the Israeli Ministry of Health were used to model the parameters of the pandemic in Israel. The Oxford COVID-19 Government Response Tracker was used for quantitative data on government policies. Data on the Israeli economy were taken from the Central Bureau of Statistics. Our models demonstrate that the first lockdown prevented 1022 COVID-19 deaths at the cost of 36.4–38.6 billion NIS. The second lockdown prevented 1970 COVID-19 deaths and cost 18–21 billion NIS. These lifesaving effects were observed with a time lag from the declaration of lockdown. The primary vaccination campaign cost 1 billion NIS and prevented 4750 COVID-19 deaths. The first vaccination booster campaign prevented 650 COVID-19 deaths and cost 51.1 million NIS. Therefore, the cost per prevented COVID-19 death is 10–36 million NIS with a national lockdown versus 210,000 NIS in the primary vaccination campaign and 79,000 NIS in the first booster campaign. In conclusion, both lockdowns and vaccination campaigns effectively lower COVID-19 deaths, but the cost to avoid one COVID-19 death with effective vaccination is 50–466 times lower than with a lockdown. MDPI 2022-08-18 /pmc/articles/PMC9413824/ /pubmed/36016236 http://dx.doi.org/10.3390/vaccines10081347 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Arbel, Ronen Pliskin, Joseph Vaccinations versus Lockdowns to Prevent COVID-19 Mortality |
title | Vaccinations versus Lockdowns to Prevent COVID-19 Mortality |
title_full | Vaccinations versus Lockdowns to Prevent COVID-19 Mortality |
title_fullStr | Vaccinations versus Lockdowns to Prevent COVID-19 Mortality |
title_full_unstemmed | Vaccinations versus Lockdowns to Prevent COVID-19 Mortality |
title_short | Vaccinations versus Lockdowns to Prevent COVID-19 Mortality |
title_sort | vaccinations versus lockdowns to prevent covid-19 mortality |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413824/ https://www.ncbi.nlm.nih.gov/pubmed/36016236 http://dx.doi.org/10.3390/vaccines10081347 |
work_keys_str_mv | AT arbelronen vaccinationsversuslockdownstopreventcovid19mortality AT pliskinjoseph vaccinationsversuslockdownstopreventcovid19mortality |